Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/20/2010EP2240461A1 Substituted furans and use thereof
10/20/2010EP2240460A2 Branched diepoxide compounds for the treatment of inflammatory disorders
10/20/2010EP2240458A1 Aryl sulfonamides as effective analgesics
10/20/2010EP2240455A1 Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
10/20/2010EP2240453A1 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
10/20/2010EP2240452A1 Certain chemical entities, compositions and methods
10/20/2010EP2240451A1 Certain chemical entities, compositions and methods
10/20/2010EP2240450A1 Trpa1 antagonists
10/20/2010EP2240449A1 Novel anti-infectious derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment
10/20/2010EP2240448A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
10/20/2010EP2240447A2 Morpholine derivates as antiobesity agents
10/20/2010EP2240445A1 Novel salt of tegaserod
10/20/2010EP2240444A1 Compounds having crth2 antagonist activity
10/20/2010EP2240440A2 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs
10/20/2010EP2240439A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
10/20/2010EP2240438A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs
10/20/2010EP2240436A1 Novel process for the preparation of vorinostat
10/20/2010EP2240434A1 2-phenyl phenoxyacetic acids useful for treating inflammatory disorders
10/20/2010EP2240431A1 Crystalline modifications of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl -propyl)-phenol
10/20/2010EP2240214A2 Analgesic apatitic calcium-phosphate cement
10/20/2010EP2240194A1 Treatment of melanoma with alpha thymosin peptides in combination with a kinase inhibitor
10/20/2010EP2240190A1 Nutraceutical composition and methods of use
10/20/2010EP2240188A1 Ointment on the basis of a dialysate of calves' blood.
10/20/2010EP2240185A2 Compositions and methods for influencing recovery from strenuous physical activity
10/20/2010EP2240182A1 Treating hyperglycemia with 25-hydroxyvitamin d3
10/20/2010EP2240181A1 Combined use of 25-hydroxy-vitamin d3 and vitamin d3 for improving bone mineral density and for treating osteoporosis
10/20/2010EP2240180A2 Prevention of recurrence of urethral stricture after a conventional treatment
10/20/2010EP2240179A2 Imidazopyridazines as par1 inhibitors, production thereof, and use as medicaments
10/20/2010EP2240178A1 Prolyl hydroxylase inhibitors
10/20/2010EP2240177A2 Treatments for neuropathy
10/20/2010EP2240176A2 Compositions and methods for enhancing the activity of podophyllotoxin
10/20/2010EP2240175A2 Compounds with mdr1-inverse activity
10/20/2010EP2240174A1 Pharmaceutical compositions comprising n-ý2-(diethylamino)ethyl¨-5-ý(5-fluoro-1,2- dihydro-2-oxo-3h-indol-3-ylidene)methyl¨-2,4-dimethyl-1h-pyrrole-3-carboxamide
10/20/2010EP2240173A1 Delayed release pharmaceutical composition of duloxetine
10/20/2010EP2240171A2 Inhibitors of carbonic anhydrase ix
10/20/2010EP2240170A2 Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
10/20/2010EP2240169A2 Cytostatic composition
10/20/2010EP2240168A2 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulators
10/20/2010EP2240167A1 Extruded rod-shaped devices for controlled release of biological substances to humans and animals
10/20/2010EP2240166A2 Mesalazine tablet
10/20/2010EP2240164A2 Pharmaceutical composition
10/20/2010EP2240161A1 Enhanced delivery of antifungal agents
10/20/2010EP2240159A2 Alendronate formulations, method of making and method of use thereof
10/20/2010EP2240158A2 Stabilized injectable formulation of pregabalin
10/20/2010EP2240153A1 Oral care regimen
10/20/2010EP2240152A1 Composition containing a retinoid and dispersed benzoyle peroxide
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP2240028A1 Organic compounds
10/20/2010EP2240026A1 NOVEL sEH INHIBITORS AND THEIR USE
10/20/2010EP2240023A2 Antiviral drugs for treatment of arenavirus infection
10/20/2010EP2240022A2 Pharmaceutical compositions
10/20/2010EP2240021A1 Novel seh inhibitors and their use
10/20/2010EP2240019A1 Acid mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase
10/20/2010EP2240016A1 Ampk modulators
10/20/2010EP2144897B1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
10/20/2010EP2125794B1 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
10/20/2010EP2114945B1 Pteridinone derivatives as pi3-kinases inhibitors
10/20/2010EP2102173B1 Pyrimidyl derivatives as protein kinase inhibitors
10/20/2010EP2049491B1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
10/20/2010EP2037889B1 Nanostructured lipid carriers containing riluzole and pharmaceutical formulations containing said particles
10/20/2010EP2029594B1 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use
10/20/2010EP2007758B1 A novel crystalline form of lamivudine
10/20/2010EP1996571B1 Tetracyclic steroid derivatives useful as progesterone receptor modulators
10/20/2010EP1984331B1 Pyrrolidine derivatives as erk inhibitors
10/20/2010EP1966199B1 Azaindole-2-carboxamide derivatives
10/20/2010EP1959933B1 Process for the preparation of lyophilized piperacillin sodium in combination with tazobactam sodium, with improved stability after reconstitution
10/20/2010EP1957060B1 Cancer treatment using fts and 2-deoxyglucose
10/20/2010EP1951653B1 Salicylic acid derivatives
10/20/2010EP1948166B1 Carbazole derivatives as functional 5-ht6 ligands
10/20/2010EP1924570B1 Azole and thiazole derivatives and their use
10/20/2010EP1921065B1 Phenylpyridone derivative
10/20/2010EP1899320B1 Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kv1 .5 potassium channel blockers and pharmaceutical preparations comprising them
10/20/2010EP1811998B1 Triazoles useful as inhibitors of protein kinases
10/20/2010EP1780197B1 5-substituted-2-phenylamino benzamides as mek inhibitors
10/20/2010EP1768984B1 Thienopyrimidines useful as aurora kinase inhibitors
10/20/2010EP1747778B1 Anti-fatigue composition
10/20/2010EP1732929B1 Tricyclic benzopyran compound as anti-arrhythmic agents
10/20/2010EP1722798B1 Pyrimidine compounds as purine receptor antagonists
10/20/2010EP1700159B1 Digital still camera with audio decoding and coding, a printable audio format, and method
10/20/2010EP1699759B1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
10/20/2010EP1689751B1 5,7-diaminopyrazolo[4,3-d]pyrimidines with pde-5 inhibiting activity
10/20/2010EP1626973B1 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
10/20/2010EP1594491B1 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections
10/20/2010EP1569929B9 Compounds and methods for the treatment or prevention of flavivirus infections
10/20/2010EP1531790B1 Cosmetic composition structured with silicone polymers and film-forming resins
10/20/2010EP1414496B1 Pharmaceutical composition containing a combinaition of ppar-alpha, pravastatin and polyglycolized glyceride
10/20/2010EP1381357B1 Glycyrrhetinic acid derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity
10/20/2010EP1366366B1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
10/20/2010EP1360508B1 Prediction of wound healing by urinary nitrate assay
10/20/2010EP1317431B1 Polyarylcarboxamides useful as lipid lowering agents
10/20/2010EP1308438B1 3-substituted urea derivatives and medicinal use thereof
10/20/2010EP1283832B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2010EP1091938B1 Antihistaminic piperidine derivatives and intermediates for the preparation thereof
10/20/2010EP0959075B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
10/20/2010EP0710280B1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
10/20/2010CN1938030B Transdermal iontophoretic delivery of piperazinyl-2(3h)-benzoxazolone compounds
10/20/2010CN1870998B Ccr-2拮抗剂盐 Ccr-2 antagonists salt
10/20/2010CN101868472A Antibacterial aminoglycoside analogs
10/20/2010CN101868469A Phosphonic acid derivates and their use as P2Y12 receptor antagonists
10/20/2010CN101868465A Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
1 ... 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 ... 7860